TrialJournal of clinical pharmacology2022

Factors Influencing Change in Serum Uric Acid After Administration of the Sodium-Glucose Cotransporter 2 Inhibitor Luseogliflozin in Patients With Type 2 Diabetes Mellitus.

Yukihiro Chino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.